Agreed! Uplist alone cures nothing! If you look at my previous post regarding the 58 companies uplisted last year.... most had lower SP after uplist. That’s a lot of data. The real meat is data on the drug. Period. That will drive SP. I’m not saying we need approval now.... just more compelling data that leads to the ultimate FDA approval. Noting happens quick in this market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.